Author(s): Ma X, Bai Y
Secretory clusterin (sCLU) is a type of stress-induced, pro-survival glycoprotein elevated in early-stage cancer. It enhances cancer cell survival and is associated with several types of cancer progression. In this study, we measured the PI3K/AKT signaling activity by determining the phosphorylation level of the AKT protein, namely pAKT. A549 human non-small cell lung carcinoma (NSCLC) cells were treated with insulin-like growth factor-1 (IGF-1) for various periods of time. The results showed that IGF-1 activated the PI3K/AKT signaling pathway in the A549 cells in a time-dependent manner. Western blot analysis was performed to determine the expression of sCLU protein in A549 cells treated with IGF-1. IGF-1 elevated the expression of sCLU. To determine whether sCLU is required for the IGF-1 activation of the PI3K/AKT signaling pathway, the A549 cells were treated with IGF-1 and sCLU antisense oligonuleotide (sCLU ASO). sCLU ASO blocked the IGF-1 activation of the PI3K/AKT signaling pathway. These results demonstrate that IGF-1 activates the P13K/AKT signaling pathway via the upregulation of sCLU. The present study implies that this pathway may uncover a new mechanism for cancer progression and reveal new targets for drug development in the treatment of NSCLC.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/23027041
Author(s): Neal JW, Gubens MA, Wakelee HA
Author(s): Chang A
Author(s): Kartalou M, Essigmann JM
Author(s): Rabik CA, Dolan ME
Author(s): Siddik ZH
Author(s): Rosenberg ME, Silkensen J
Author(s): Niu ZH, Wang Y, Chun B, Li CX, Wu L
Author(s): Zoubeidi A, Chi K, Gleave M
Author(s): Yang GF, Li XM, Xie D
Author(s): He LR, Liu MZ, Li BK, Rao HL, Liao YJ, et al.
Author(s): Xie MJ, Motoo Y, Su SB, Mouri H, Ohtsubo K, et al.
Author(s): Park DC, Yeo SG, Wilson MR, Yerbury JJ, Kwong J, et al.
Author(s): Wang Y, Wang X, Zhao H, Liang B, Du Q
Author(s): Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, et al.
Author(s): Yan Y, Luo K, Zhang H, Chai W
Author(s): Cheng CY, Cherng SH, Wu WJ, Yang TY, Huang XY, et al.
Author(s): Laskin JJ, Nicholas G, Lee C, Gitlitz B, Vincent M, et al.
Author(s): Cao C, Shinohara ET, Li H, Niermann KJ, Kim KW, et al.
Author(s): Bortul R, Tazzari PL, Billi AM, Tabellini G, Mantovani I, et al.
Author(s): Liu D, Zhang Y, Dang C, Ma Q, Lee W, et al.
Author(s): Guinea Viniegra J, Hernández Losa J, Sánchez-Arévalo VJ, ParadaCobo C, FernándezSoria VM, et al.
Author(s): McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, et al.
Author(s): McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, et al.
Author(s): Sridhar SS, Hedley D, Siu LL
Author(s): Tang Y, Liu F, Zheng C, Sun S, Jiang Y
Author(s): Si H, Peng C, Li J, Wang X, Zhai L, et al.
Author(s): Zhou L, Luan H, Liu Q, Jiang T, Liang H, et al.
Author(s): Li H, Schmid-Bindert G, Wang D, Zhao Y, Yang X, et al.
Author(s): Lee HY, Oh SH, Suh YA, Baek JH, Papadimitrakopoulou V, et al.
Author(s): Wang M, Liu ZM, Li XC, Yao YT, Yin ZX
Author(s): Li J, Jia L, Zhao P, Jiang Y, Zhong S, et al.
Author(s): Xiu P, Dong X, Dong X, Xu Z, Zhu H, et al.
Author(s): Scaltriti M, Bettuzzi S, Sharrard RM, Caporali A, Caccamo AE, et al.
Author(s): Manic S, Gatti L, Carenini N, Fumagalli G, Zunino F, et al.
Author(s): Springate CM, Jackson JK, Gleave ME, Burt HM
Author(s): Miyake H, Hara S, Zellweger T, Kamidono S, Gleave ME, et al.
Author(s): Hoeller C, Pratscher B, Thallinger C, Winter D, Fink D, et al.
Author(s): Redondo M, Téllez T, Roldan MJ, Serrano A, GarcÃa-Aranda M, et al.
Author(s): Lourda M, Trougakos IP, Gonos ES
Author(s): Karaca B, Atmaca H, Bozkurt E, Kisim A, Uzunoglu S, et al.
Author(s): Pajak B, Orzechowski A
Author(s): Peyssonnaux C, Eychène A
Author(s): Zhuang S, Schnellmann RG
Author(s): Ko JC, Tsai MS, Chiu YF, Weng SH, Kuo YH, et al.
Author(s): Gozdz A, Habas A, Jaworski J, Zielinska M, Albrecht J, et al.
Author(s): Huang WC, Hung MC
Author(s): Seo JH, Jeong ES, Lee KS, Heo SH, Jeong DG, et al.